Parvus Asset Management is building a stake in Novo Nordisk and hopes to influence its choice of a new CEO. Novo Nordisk ...

Why Might Some People Opt to Take an Oral Version of Wegovy Instead of Injections? There are multiple reasons why someone ...

June 10, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Com Novo Nordisk to present data from STEP UP trial on a higher dose of Wegovy® (semaglutide ... of full Phase 3 ...

After 12 weeks, weight loss with the drug was 13% of body weight, compared to 1% with placebo, which the company said was around twice the level achieved with Wegovy ... in the STEP 9 trial.

Among dozens of new laws signed this week by Gov. Jared Polis are consumer-friendly rules making it easier to cancel services ...

Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...

When it rebranded as WW, it looked like the writing was on the wall for WeightWatchers. BBD Perfect Storm Health’s Nick ...

S&P 500, Eli Lilly and Company, Novo Nordisk A/S Class B, Novo Nordisk A/S. Read 's Market Analysis on Investing.com ...

Hedge fund aims to influence CEO appointment as drugmaker battles share price slump and competition from Eli Lilly.

Unlike injectable weight loss drugs that often serve as a temporary fix, Elcella seeks to naturally activate the gut’s own ...

A popular weight-loss drug may be changing how doctors treat obesity—but scientists are just starting to uncover exactly how ...